methsuximide Oral Capsule

Brand(s)
Celontin
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Parke-Davis Div Of Pfizer Inc (2014-07-25)
Oldest Current Product
1957-02-08
License(s)
NDA
RxNORM
ORAL CAPSULE\METHSUXIMIDE
FDAOB
ORAL\CAPSULE\METHSUXIMIDE
SPL Active
ORAL\CAPSULE\METHSUXIMIDE
SPL Moiety
ORAL\CAPSULE\METHSUXIMIDE

product(s) by strength(s)

methsuximide 300 mg oral capsule

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1000710525CelontinNDAParke-Davis Div Of Pfizer Inc1957-02-08METHSUXIMIDEORALCAPSULENDA01059664a6ee88-c6b1-4e13-8208-b6772ef65a74

application(s)

#idtitleapplicantapproved drug
1NDA010596CELONTINPARKE DAVIS DIV WARNER LAMBERT CONDA010596_007, NDA010596_008

application drug(s)

#idcategory/deprecatedingredient strength(s)routedose formrldapplication
1NDA010596_007RXMETHSUXIMIDE (150MG)ORALCAPSULEFalseCELONTIN
2NDA010596_008RXMETHSUXIMIDE (300MG)ORALCAPSULETrueCELONTIN

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
164a6ee88-c6b1-4e13-8208-b6772ef65a74 (view SPL)Celontin (Methsuximide Capsules, USP)prescriptionHuman PrescriptionParke-Davis Div Of Pfizer IncANALYSIS, API MANUFACTURE, MANUFACTURE, PACK2014-07-2511000710525

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII